Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2013
Targeting fibroblast growth factor pathways in prostate cancer
Paul G Corn, Fen Wang, Wallace L McKeehan, et al.
Biomaterials
|
January 26, 2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro
Claudia Paindelli, Nora Navone, Christopher J Logothetis, et al.
The Prostate
|
May 3, 2002
Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells
Genevieve M Vidanes, Vince Paton, Eric Wallen, et al.
Plos One
|
November 14, 2013
Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells
Mercedes Ferrando, Xinhai Wan, Roberto Meiss, et al.
Oncotarget
|
December 18, 2018
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
Michelle Faria, Peter Shepherd, Yinghong Pan, et al.
Antioxidants & Redox Signaling
|
December 22, 2019
Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis
Nicolás Anselmino, Michael Starbuck, Estefania Labanca, et al.
The Journal of Biological Chemistry
|
January 29, 2002
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2
Zhi Wang, Ching-Ping Tseng, Rey-Chen Pong, et al.
Biomolecules
|
July 10, 2020
Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer
Emiliano Ortiz, Pablo Sanchis, Juan Bizzotto, et al.
Molecular Cancer Research : MCR
|
April 22, 2024
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer
Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova, et al.
Molecular Cancer Research : MCR
|
November 12, 2009
Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells
Geraldine Gueron, Adriana De Siervi, Mercedes Ferrando, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2013
Targeting fibroblast growth factor pathways in prostate cancer
Paul G Corn, Fen Wang, Wallace L McKeehan, et al.
Biomaterials
|
January 26, 2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro
Claudia Paindelli, Nora Navone, Christopher J Logothetis, et al.
The Prostate
|
May 3, 2002
Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells
Genevieve M Vidanes, Vince Paton, Eric Wallen, et al.
Plos One
|
November 14, 2013
Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells
Mercedes Ferrando, Xinhai Wan, Roberto Meiss, et al.
Oncotarget
|
December 18, 2018
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
Michelle Faria, Peter Shepherd, Yinghong Pan, et al.
Antioxidants & Redox Signaling
|
December 22, 2019
Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis
Nicolás Anselmino, Michael Starbuck, Estefania Labanca, et al.
The Journal of Biological Chemistry
|
January 29, 2002
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2
Zhi Wang, Ching-Ping Tseng, Rey-Chen Pong, et al.
Biomolecules
|
July 10, 2020
Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer
Emiliano Ortiz, Pablo Sanchis, Juan Bizzotto, et al.
Molecular Cancer Research : MCR
|
April 22, 2024
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer
Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova, et al.
Molecular Cancer Research : MCR
|
November 12, 2009
Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells
Geraldine Gueron, Adriana De Siervi, Mercedes Ferrando, et al.
Page
of 5